Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?
Neurotherapeutics - United States
doi 10.1007/s13311-018-0668-6
Full Text
Open PDFAbstract
Available in full text
Date
September 21, 2018
Authors
Publisher
Springer Science and Business Media LLC